Achieve Your Unique Goals
Practical Solutions, Fast
Welcome to Cartco Consulting Ltd, a London-based strategy consulting firm that specializes in offering value creation, operations strategy, and M&A services to small and medium-sized enterprises globally in industries like Professional Services and Life Sciences. We partner with your business to deliver tailor-made practical solutions, fast.
How We Make A Difference
At Cartco Consulting Ltd, we believe that with our help, your business can do more. Our London-based strategy consulting firm has a proven track record of supporting businesses in a variety of industries through results-driven consulting. We'll give your company the attention it deserves, offering personalized solutions and guidance to help you meet and surpass your goals.
The Founder
James Cartwright is an experienced and dynamic leader with a background in both Life Sciences and Commercial Operations. James has worked on projects ranging from London based start-ups through to share price sensitive projects with FTSE 100 companies.
James holds an Executive MBA in Strategy and Corporate Finance (Bayes Business School 2014).
He is also a Fellow of the Royal Society of Chemistry and a Qualifed Lean-Sigma Practitioner with over 20 years experience in Lean-Sigma.
​
E-mail: james@cartco.org.uk
Case Studies
Our Reputation Speaks for Itself
At Cartco Consulting Ltd, we believe that successful collaborations are one of the most rewarding outcomes in business. We use our experience and knowledge to create lasting and rewarding relationships with our business partners.
UK HealthTech Charity
Designed the commercial business operations function including IT, Finance, Legal, Quality Assurance and HR functions.
Redesign Finance Department
Lead a significant organisational re-design to deliver cost savings (£11 million) and re-shape the commercial partnering model for a global R&D division.
Clinical Operations
Delivered a complex change management project across 42 countries, resulting in an annual cost savings of £30 million and improving operational efficiency in the delivery of clinical trials.